Biora Therapeutics Inc logo

Biora Therapeutics Inc

1
NEW
NAS:BIOR (USA)   Ordinary Shares
$ 3.43 -0.05 (-1.44%) 04:00 PM EST
At Loss
Market Cap:
$ 12.62M
Enterprise V:
$ 54.44M
Volume:
43.48K
Avg Vol (2M):
48.14K
Trade In:
Volume:
43.48K
At Loss
Avg Vol (2M):
48.14K

Business Description

Biora Therapeutics Inc logo
Biora Therapeutics Inc
NAICS : 541714 SIC : 2833
ISIN : US74319F3055

Share Class Description:

BIOR: Ordinary Shares
Description
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.11
Equity-to-Asset -4.89
Debt-to-Equity -0.53
Debt-to-EBITDA -0.6
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -89.3
Distress
Grey
Safe
Beneish M-Score -3.17
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 32.14
9-Day RSI 33.18
14-Day RSI 33.97
6-1 Month Momentum % -23.47
12-1 Month Momentum % -75.29

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.2
Quick Ratio 0.2
Cash Ratio 0.12

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -131.9
Shareholder Yield % 489.45

Financials (Next Earnings Date:2024-11-13 Est.)

BIOR's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BIOR

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Biora Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.86
EPS (TTM) ($) -56.9
Beta 2.26
Volatility % 79.06
14-Day RSI 33.97
14-Day ATR ($) 0.549687
20-Day SMA ($) 4.83235
12-1 Month Momentum % -75.29
52-Week Range ($) 3.35 - 20.5
Shares Outstanding (Mil) 3.68

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Biora Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Biora Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Biora Therapeutics Inc Frequently Asked Questions

What is Biora Therapeutics Inc(BIOR)'s stock price today?
The current price of BIOR is $3.43. The 52 week high of BIOR is $20.50 and 52 week low is $3.35.
When is next earnings date of Biora Therapeutics Inc(BIOR)?
The next earnings date of Biora Therapeutics Inc(BIOR) is 2024-11-13 Est..
Does Biora Therapeutics Inc(BIOR) pay dividends? If so, how much?
Biora Therapeutics Inc(BIOR) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1